VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Northrop Grumman Corporation vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Northrop Grumman Corporation
NOC · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Northrop Grumman Corporation's moat claims, evidence, and risks.
View NOC analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Sanofi leads (74 / 100 vs 72 / 100 for Northrop Grumman Corporation).
- Segment focus: Northrop Grumman Corporation has 4 segments (28.7% in Aeronautics Systems); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Moat breadth: Northrop Grumman Corporation has 6 moat types across 3 domains; Sanofi has 5 across 3.
Primary market context
Northrop Grumman Corporation
Aeronautics Systems
Military aircraft systems (manned & unmanned) plus sustainment/modernization
Global (primarily United States and allies)
U.S. government and allied governments
Prime contractor and major subsystem supplier
28.7%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Northrop Grumman Corporation strengths
Sanofi strengths
Segment mix
Northrop Grumman Corporation segments
Full profile >Aeronautics Systems
Oligopoly
Defense Systems
Oligopoly
Mission Systems
Oligopoly
Space Systems
Oligopoly
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.